FANCL
About
Location: 2p16.1
Mappings
Biomarkers
FANCL is involved in the following curated biomarkers.
| Name | Biomarker type | Propositions | Statements |
|---|---|---|---|
| FANCL pathogenic variants | Germline Variant | 1 | 1 |
| FANCL oncogenic variants | Somatic Variant | 1 | 1 |
Therapeutic response
Precision oncology relationships for therapeutic response involving this gene.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| FDA (1) | FANCL pathogenic variants | Prostate Adenocarcinoma | Olaparib | |
| FDA (1) | FANCL oncogenic variants | Prostate Adenocarcinoma | Olaparib |